Free Trial

Profound Medical (PROF) Earnings Date, Estimates & Call Transcripts

Profound Medical logo
$7.35
+0.08 (+1.10%)
(As of 11/1/2024 ET)

Profound Medical Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 7After Market ClosesConfirmed
Actual EPS
(Aug. 8)
-$0.28
Consensus EPS
(Aug. 8)
-$0.28

Profound Medical posted Q2 2024 earnings on August 8, 2024, reporting an EPS of -$0.28, which met analysts' consensus estimates of -$0.28. Quarterly revenue was reported to be $2.23 million, below analyst estimates of $2.50 million. With a trailing EPS of -$1.22, Profound Medical's earnings are expected to grow next year, from ($1.19) to ($0.84) per share.

PROF Upcoming Earnings

Profound Medical's next earnings date is scheduled for Thursday, November 7, 2024.

Get Profound Medical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Profound Medical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PROF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PROF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Profound Medical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.30-$0.30-$0.30
Q2 20241-$0.29-$0.29-$0.29
Q3 20241-$0.29-$0.29-$0.29
Q4 20241-$0.28-$0.28-$0.28
FY 20244-$1.16-$1.16-$1.16
Q1 20251-$0.21-$0.21-$0.21
Q2 20251-$0.18-$0.18-$0.18
Q3 20251-$0.14-$0.14-$0.14
Q4 20251-$0.10-$0.10-$0.10
FY 20254($0.63)($0.63)($0.63)

Profound Medical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/7/2024
(Confirmed)
------- 
8/8/2024Q2 2024-$0.28-$0.28--$0.28$2.50M$2.23M  
5/9/2024Q1 2024-$0.31-$0.26+$0.05-$0.26$2.40M$1.91M  
3/7/2024Q4 2023-$0.28-$0.42 -$0.14-$0.42$1.90M$2.01M  
11/2/2023Q3 2023-$0.32-$0.26+$0.06-$0.26$2.40M$1.73M  
8/9/2023Q2 2023-$0.31-$0.35 -$0.04-$0.35$2.05M$1.60M  
5/10/2023Q1 2023-$0.38-$0.32+$0.06-$0.32$1.85M$1.86M  
3/7/2023Q4 2022--$0.46 -$0.46-$0.46$2.20M$1.26M  
11/3/2022Q3 2022-$0.34-$0.24+$0.10-$0.24$2.40M$2.04M  

Profound Medical Earnings - Frequently Asked Questions

Profound Medical has confirmed that its next quarterly earnings data will be published on Thursday, November 7th, 2024. Learn more on PROF's earnings history.

Profound Medical updated its FY 2024 earnings guidance on Thursday, August, 8th. The company issued revenue guidance of $11.0 million-$12.0 million, compared to the consensus revenue estimate of $11.3 million.

In the previous quarter, Profound Medical (NASDAQ:PROF) reported ($0.28) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.28). Learn more on analysts' earnings estimate vs. PROF's actual earnings.

Profound Medical (NASDAQ:PROF) has a recorded annual revenue of $7.20 million.

Profound Medical (NASDAQ:PROF) has a recorded net income of -$28.57 million. PROF has generated -$1.22 earnings per share over the last four quarters.

Profound Medical's earnings are expected to grow from ($1.19) per share to ($0.84) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:PROF) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners